Investor Alert

London Markets Close in:

Jan. 17, 2021, 12:08 a.m. EST

Pancreatic Cancer Market Overview, Sales Revenue, Opportunities, Size, Share, Competitive Landscape and Comprehensive Research Study 2024

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jan 17, 2021 (Heraldkeepers) -- Pancreatic Cancer Market Information: By Type (Endocrine Pancreas Cancer and Exocrine Pancreas Cancer), Treatment (Hormone Therapy, Biologic Therapy, and Targeted Therapy), End User (Hospitals & Clinics and Research Institute) - Global Forecast till 2023

Pancreatic Cancer Market Overview:

The global pancreatic cancer market is expected to grow at a CAGR of 8.1% over the forecast period from 2017 to 2023, according to a new research report from Market Research Future (MRFR). The market is mainly driven by the growing prevalence of pancreatic cancer in the developed world and the growing efforts by government agencies to keep the disease under control.

Pancreatic cancer was the twelfth most common type of cancer around the world in 2015 according to the WHO and is likely to remain a major health threat over the forecast period. The main problem with pancreatic cancer is that it is much harder to detect in the early stages than other cancers and it is also more painful. Early-stage treatment is crucial in avoiding the full-blown impact of pancreatic cancer. This is likely to be a major target for players in the global pancreatic cancer market, as early stage diagnosis improves the prognosis of the patients considerably and makes it much easier to treat the disease.

Also Read: https://www.medgadget.com/2020/02/pancreatic-cancer-treatment-market-size-is-projected-to-grow-at-a-cagr-of-8-1-by-2023.html

Increasing cancer research is likely to fuel the global pancreatic cancer market over the forecast period. The increasing healthcare threat of cancer is being acknowledged by a growing number of governments around the world, which are funding significant research efforts in order to learn more about the disease and develop effective treatment mechanisms. This is likely to be a major driver for the global pancreatic cancer market over the forecast period as healthcare agencies around the world step up their efforts to combat the threat of cancer.

On the other hand, the need for expensive equipment in treating pancreatic cancer and the lack of adequate reimbursement options, especially in developing countries, is likely to act as a key restraint against the global pancreatic cancer market over the forecast period.

Competitive Analysis:

Leading players in the global Pancreatic Cancer Market include Pharmacyte Biotech Inc., Oncolytics Biotech, Polaris Pharmaceuticals Inc., Midatech Pharma plc, Celgene Corporation, Amgen Inc., Clovis Oncology, Novartis International AG, F. Hoffman-La Roche AG, Eli Lilly and Company, Sun BioPharma Inc., Diffusion Pharmaceuticals, and OncoGenex Pharmaceuticals Inc.


The global pancreatic cancer market is segmented on the basis of type, treatment, and end user.

On the basis of type, the pancreatic cancer market is segmented into endocrine pancreatic cancer, exocrine pancreatic cancer, and others.

On the basis of the treatment, the pancreatic cancer market is segmented into chemotherapy, surgery & radiation therapy, targeted therapy, biologic therapy, hormone therapy, and others. Furthermore, the chemotherapy segment is sub-segmented into antimetabolites, anthracyclines, taxanes, and alkylating agents. The targeted therapy segment is sub-segmented into tyrosine kinase inhibitors and monoclonal antibodies. The hormone therapy segment is further sub-segmented into estrogen-receptor modulators, aromatase inhibitors, and others.

On the basis of end use, the market is segmented into hospitals & clinics, research institutes, and others.

Regional Analysis:

The global pancreatic cancer market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa on the basis of region. The global pancreatic cancer market is dominated by the Americas segment due to the growing demand for effective cancer medication in the region and the growing government efforts to step up cancer research. The growing number of major drug manufacturers operating in the region is also likely to be a major driver for the Americas market for pancreatic cancer over the forecast period.

Asia Pacific is likely to exhibit the fastest growth in the global pancreatic cancer market over the forecast period due to the growing prevalence of the disease and the resultant increase in the awareness about the disease among the population. Countries such as South Korea and India are likely to emerge as major markets for pancreatic cancer over the forecast period.

Get Full Report at https://www.marketresearchfuture.com/reports/pancreatic-cancer-market-1638

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.